Clinical Trial Update: Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of OPC-34712 on QT/QTc in subjects with schizophrenia or schizoaffective disorder; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• OPC-34712

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED | Results posted: 2015-10-29